Novavax's stock is down 6% after missing revenue expectations for the fourth quarterMarket Watch • 03/01/22
Novavax, Inc. (NVAX) CEO Stanley Erck on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/01/22
Novavax Reports Fourth Quarter and Full Year 2021 Financial Results and Operational HighlightsPRNewsWire • 02/28/22
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical TrialPRNewsWire • 02/28/22
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022PRNewsWire • 02/21/22
3 Supercharged Growth Stocks With 126% to 248% Upside, According to Wall StreetThe Motley Fool • 02/17/22